- What We Do
- Get Involved
- Our Impact
- Our Events
- Boston Bakes for Breast Cancer
- Cape & Islands Bakes for Breast Cancer
- Rhode Island Bakes for Breast Cancer
- Cooking Classes
- What We Fund
- Bake Sale
- Office Bake Sale
- Event Registration
- Contact Us
Category Archives: Dana-Farber
Executive Pastry Chef Valerie Nin of Grill 23 & Bar is one of five of the extraordinary Pastry Chef’s taking part in Sugar Rush 2017 on Monday, July 17 at 6:00 PM at the Rail Stop in Brighton. Get your ticket on EventBrite and join us as we not only enjoy a 5-course dessert tasting but raise much needed money for breast cancer research.
Valerie NinExecutive Pastry ChefGrill 23 & Bar
Valerie Nin is the Executive Pastry Chef at Grill 23 & Bar, Boston’s premier steakhouse and seafood grill, where she oversees the restaurant’s pastry program. Valerie uses seasonal ingredients to create …
Pastry Chef Jaime Davis Schick is one of five of the extraordinary Pastry Chef’s taking part in Sugar Rush 2017 on Monday, July 17 at 6:00 PM at the Rail Stop in Brighton. Get your ticket on EventBrite and join us as we not only enjoy a 5-course dessert tasting but raise much needed money for breast cancer research.
Jaime Davis SchickExecutive Pastry Chef
Jaime Davis Schick is a New Hampshire native whose passion for food and cooking is in her blood; her father is a culinary professional and her grandmother, who Schick remembers baking with as a young girl, attended Fannie …
Bakes for Breast Cancer 2017 will support the research of Dr. Shom Goel
Although the term “physician-scientist” has become a buzzword in medical research, there are actually only a few people around who successfully combine a career in the clinic, taking care of breast cancer patients, with laboratory research. Dr Shom Goel is one such person – a breast cancer oncologist at the Dana-Farber who divides his time between the laboratory bench and the patient’s bedside. This year, we will be funding Dr. Goel and his research that addresses the important question – “Why are some breast cancers resistant to the …
Dana-Farber Cancer Institute, Lifespan sign long-term agreement to advance cancer treatment and research
March 21, 2017 Courtesy of Dana-Farber Cancer Institute
Dana-Farber Cancer Institute and Lifespan leadership are creating a strategic alliance to advance cancer treatment and research. The new agreement, signed March 21, 2017, will support the expansion of clinical trials, offer access for Lifespan physicians to cancer-specific disease expertise for complex cases, and create a program to coordinate the treatment of bone marrow transplant patients, with transplants provided in Boston at Dana-Farber/Brigham and Women’s Cancer Center and care surrounding the transplant in Rhode Island at Lifespan. The two organizations already share patient information through their respective cancer-specific electronic health record systems and …
Dana-Farber scientists this year identified a promising new drug for a form of breast cancer and discovered one way the disease can outmaneuver the drug. The findings, reported in the journal Nature, may lead to a more farsighted treatment strategy for breast cancers classified as “triple-negative” – one that uses drug combinations to both arrest the disease and prevent it from resisting front-line therapies. The dual approach could significantly extend patient survival times, the authors say.
Kornelia Polyak, M.D., Ph.D.
“We found that a class of agents known as BET bromodomain inhibitors significantly impeded the growth of triple-negative breast cancer cells in …
As you guys know, April is Cancer Control Month. So I thought I would take the time to highlight a young researcher looking for biological predispositions and responses to breast cancer in the bodies of women: Dr. Heather Parsons. A graduate of Dartmouth College, she also received her Masters in Public Health from Johns Hopkins Bloomberg School of Public Health. After receiving her medical degree from Drexel University, she eventually completed her residency and fellowship at John Hopkins Hospital and joined Dana-Farber Cancer Institute.
Now a medical oncologist for the Dana-Farber Cancer Institute and an instructor at Harvard Medical School, Dr. …
The stars of tomorrow are the young investigators of today.
Bakes for Breast Cancer will now be funding the up and coming research of young investigators in breast cancer research. Our Medical Advisory Board will direct the best use of our funds raised in the support of the young investigators.
Funds raised in 2015 and 2016 will benefit the research of Heather A. Parsons, MD, MPH. a young investigator at Dana-Farber Cancer Institute in Boston, Massachusetts.
Heather A. Parsons, MD, MPH
We would like to introduce you to Dr. Heather Parsons and how the money that will be raised through our events in 2016 …
In 1990, when we started The Eva Brownman Breast Cancer Fund at Dana-Farber Cancer Institute in Boston, we provided seed money for the tamoxifen research being done by Dr. Judy Garber. Dr. Garber was then a young investigator.
Dr. Garber is now internationally known for your work in the field of breast cancer. She is the Director of the Center for Cancer Genetics and Prevention at Dana-Farber and a professor at Harvard Medical School. Dr. Garber’s extensive research and work in the field of breast cancer has changed the lives of women throughout the world.
As we look back as well as …
Michael Selsman with wife Kara and sons Adam and Jacob at Dana-Farber’s annual Male Breast Cancer Awareness Week event
When Michael Selsman came home from his morning jog two years ago, he noticed a lump on his chest. It was strange, because he’d never seen it before, but he figured it was probably just an irritation. A couple of weeks passed, and the lump grew larger. So Michael made an appointment with his doctor. The results were surprising — stage IV breast cancer.
“I was shocked. I’d never heard of men getting breast cancer. It took me a while to even drag …
For many women with localized breast cancer, a lumpectomy followed by breast radiation therapy may be the most effective treatment, with survival rates equal to a mastectomy. But if the cancer comes back, can women have additional lumpectomies?
Women should not have a second lumpectomy in the same breast if they were previously
Mehra Golshan, MD, FACS, director of Breast Surgical Services with the Susan F. Smith Center for Women’s Cancers at Dana-Farber, meets with patients to customize breast surgery approaches.
treated with a lumpectomy and radiation, says Mehra Golshan, MD, FACS, director of Breast Surgical Services at the Susan F. Smith Center …